Unichem Laboratories’ wholly-owned-subsidiary -- Unichem Pharmaceuticals (USA), Inc. has voluntarily recalled 500-count bottles of Buspirone Hydrochloride Tablets, USP (5 mg), distributed in the United States. Unichem Pharmaceuticals (USA) has recalled the product after out-of-specification (OOS) assay result identified at the 12-month long-term stability time point.
Unichem has not received any reports of any adverse events related to this recall to date. The company places the highest priority on ensuring patient safety and maintaining product quality throughout every stage of its manufacturing and supply chain processes.
Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: